{"nct_id":"NCT01270464","title":"A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma","status":"COMPLETED","status_verified_date":"2016-04","start_date":"2011-02","start_date_type":null,"primary_completion_date":"2013-09","primary_completion_date_type":"ACTUAL","completion_date":"2013-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TEVA"]}